Smartphone app to manage haemophilia treatment

22 July 2010

FactorTrack is a free mobile application that helps make it easier to track and record haemophilia factor VIII infusions.

Produced by Bayer HealthCare, Pharmaceuticals FactorTrack captures dosing history, frequency and locations of bleeds.

It allows people with haemophilia A to customize their infusion schedule based on their prescribed regimen, view their infusion history and, with an Internet connection, display an alert when it's time for the next infusion. It also gives patients the option of emailing infusion and bleed history to themselves or their healthcare team if email is configured on their device. Further, FactorTrack links people with haemophilia A to educational tools and online resources.

Any person who treats his or her bleeds with factor VIII infusions can use FactorTrack, regardless of the specific product or therapy. For those on a prophylaxis (preventive) regimen, the application offers a reminder system to help make it easier to remember when to infuse. For those who infuse factor VIII on demand (when needed), the application serves as a diary to record bleeds and infusions.

"FactorTrack is the latest innovation from Bayer that illustrates our ongoing commitment to helping enhance the lives of people who live with bleeding disorders," said Paul Bedard, vice president and general manager, Hematology, Bayer HealthCare Pharmaceuticals Inc. "We worked alongside the haemophilia community, physical therapists and physical educators to develop the application in response to the needs of people with haemophilia A."

Designed to be compatible with a number of smart phone platforms, FactorTrack is available already on an iPhone, iPod touch or iPad. It will be made available on other smart phones and the Web.

People can get information about downloading FactorTrack by going to

About Haemophilia A

Haemophilia A, also known as factor VIII deficiency or classic haemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Haemophilia A, the most common type of haemophilia, is caused by deficient or defective blood coagulation proteins, known as factor VIII. Haemophilia A is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately one in 5,000 males born in the United States has haemophilia.

To top